Hyperlipidemia (E.G., Hypercholesterolemia)
5
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
7 treatments under study, led by Br10182
Research Leaders
9 sponsors active, led by University of California, Los Angeles
Related Conditions
Often studied with 15 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (5)
Efficacy and Safety of Atorvastatin and Ezetimibe (10/10mg) Fixed Dose Combination Versus Atorvastatin (20mg) Monotherapy in Bangladeshi Population
Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors
Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study
Cardiovascular Risk Reduction in Epilepsy
A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects
Research Network
Common Treatments
- Br101821
- Pc2 Primary Care Connect1
- Br101811
- Atorvastatin1
- Atorvastatin 10 Mg And Ezetimibe 10 Mg1
Active Sponsors
- University of California, Los Angeles1
- University of Louisville1
- Congressionally Directed Medical Research Programs1
- Dr. Md. Alimur Reza1
- University of Rhode Island1
Top Investigators
Professor, Dept. of Cardiology, Popular Medical College, Dhaka.
The University of Rhode Island
Rutgers, The State University of New Jersey
University of California, Los Angeles
Related Conditions
- Hypertension3
- Diabetes Mellitus1
- Military Exposure1
- Breast Cancer Early Stage Breast Cancer Stage 131
- Forever Chemicals1